The EPIFARM Study: An Observational Study in 574 Community Pharmacies in Spain Characterizing Patient Profiles of Men Asking for Erectile Dysfunction Medication

Journal of Sexual Medicine

Volumn 7, Issue 9, 2010, Pages 3153-3160

  Martín Morales, Antonio ^a   Ibáñez, José ^b   Machuca, Manuel ^c   Pol Yanguas, Emilio ^d   Schnetzler, Gabriel ^e   Renedo, Virginia Pascual ^f  

^a HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^b President of Spanish Society of Community Pharmacy ^*  (Spain)

^c UNIVERSITY OF SEVILLE   (Spain)

^d Community Pharmacist ^*  (Spain)

^e Prism Ideas Ltd   (Switzerland)

^f PFIZER INC   (United States)

Author keywords

Erectile dysfunction; Non prescription medicine; PDE5i; Pharmacist; Prescription medicine

Indexed keywords

PHOSPHODIESTERASE V INHIBITOR;

ADULT; ARTICLE; BODY WEIGHT; CLINICAL FEATURE; COMORBIDITY; CONSULTATION; CONTINUING EDUCATION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEMOGRAPHY; DEPRESSION; DIABETES MELLITUS; DISEASE DURATION; DISEASE SEVERITY; DYSLIPIDEMIA; ERECTILE DYSFUNCTION; HEALTH CARE PERSONNEL; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; INTERPERSONAL COMMUNICATION; LIFE SATISFACTION; MAJOR CLINICAL STUDY; MALE; MENTAL STRESS; OBSERVATIONAL STUDY; PATIENT ATTITUDE; PHARMACIST; PHARMACY; PRESCRIPTION; PRIORITY JOURNAL; QUESTIONNAIRE; SEXUAL HEALTH; SPAIN;

EID: 77956282131     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2010.01918.x     Document Type: Article

References (27)

1. Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: Results of the Massachusetts male aging study. J Urol 1994, 151:54-61.
2. Mulhall J, King R, Glina S, Hvidsten K. Importance of and satisfaction with sex among men and women worldwide: Results of the global better sex survey. J Sex Med 2008, 5:788-95.
3. Mulhall J, Althof SE, Brock GB, Goldstein I, Junemann KP, Kirby M. Erectile dysfunction: Monitoring response to treatment in clinical practice-Recommendations of an international study panel. J Sex Med 2007, 4:448-64.
4. Althof SE, Cappelleri JC, Shpilsky A, Stecher V, Diuguid C, Sweeney M, Duttagupta S. Treatment responsiveness of the self-esteem and relationship questionnaire in erectile dysfunction. Urology 2003, 61:888-92.
5. Kadioglu A, Grohmann W, Depko A, Levinson IP, Sun F, Collins S. Quality of erections in men treated with flexible-dose sildenafil for erectile dysfunction: Multicenter trial with a double-blind, randomized, placebo-controlled phase and an open-label phase. J Sex Med 2008, 5:726-34.
6. Cappelleri JC, Bushmakin AG, Symonds T, Schnetzler G. Scoring correspondence in outcomes related to erectile dysfunction treatment on a 4-point scale (SCORE-4). J Sex Med 2009, 6:809-19.
7. McVary KT. Clinical practice. Erectile dysfunction. N Engl J Med 2007, 357:2472-81.
8. Thompson IM, Tangen CM, Goodman PJ, Probstfield JL, Moinpour CM, Coltman CA. Erectile dysfunction and subsequent cardiovascular disease. JAMA 2005, 294:2996-3002.
9. Jackson G. Prevention of cardiovascular disease by the early identification of erectile dysfunction. Int J Impot Res 2008, 20(2):S9-14. suppl
10. Hodges LD, Kirby M, Solanki J, O'Donnell J, Brodie DA. The temporal relationship between erectile dysfunction and cardiovascular disease. Int J Clin Pract 2007, 61:2019-25.
11. Lue TF, Giuliano F, Montorsi F, Rosen RC, Andersson KE, Althof S, Christ G, Hatzichristou D, Hirsch M, Kimoto Y, Lewis R, McKenna K, MacMahon C, Morales A, Mulcahy J, Padma-Nathan H, Pryor J, de Tejada IS, Shabsigh R, Wagner G. Summary of the recommendations on sexual dysfunctions in men. J Sex Med 2004, 1:6-23.
12. Kubin M, Wagner G, Fugl-Meyer AR. Epidemiology of erectile dysfunction. Int J Impot Res 2003, 15:63-71.
13. Claes H, Opsomer RJ, Andrianne R, Vanbelle S, Albert A, Vanderdonck F. Characteristics and expectations of patients with erectile dysfunction: Results of the SCORED study. Int J Impot Res 2008, 20:418-24.
14. Haro JM, Beardsworth A, Casariego J, Gavart S, Hatzichristou D, Martin-Morales A, Schmitt H, Mirone V, Needs N, Riley A, Varanese L, von Keitz A, Kontodimas S. Treatment-seeking behavior of erectile dysfunction patients in Europe: Results of the erectile dysfunction observational study. J Sex Med 2006, 3:530-40.
15. Berner MM, Leiber C, Kriston L, Stodden V, Gunzler C. Effects of written information material on help-seeking behavior in patients with erectile dysfunction: A longitudinal study. J Sex Med 2008, 5:436-47.
16. Fisher WA, Rosen RC, Eardley I, Niederberger C, Nadel A, Kaufman J, Sand M. The multinational Men's Attitudes to Life Events and Sexuality (MALES) Study Phase II: Understanding PDE5 inhibitor treatment seeking patterns, among men with erectile dysfunction. J Sex Med 2004, 1:150-60.
17. Anderson C, Blenkinsopp A, Armstrong M. Feedback from community pharmacy users on the contribution of community pharmacy to improving the public's health: A systematic review of the peer reviewed and non-peer reviewed literature 1990-2002. Health Expect 2004, 7:191-202.
18. Hassell K, Noyce PR, Rogers A, Harris J, Wilkinson J. A pathway to the GP: The pharmaceutical " consultation" as a first port of call in primary health care. Fam Pract 1997, 14:498-502.
19. Hammerlein A, Griese N, Schulz M. Survey of drug-related problems identified by community pharmacies. Ann Pharmacother 2007, 41:1825-32.
20. McKay D. Nutrients and botanicals for erectile dysfunction: Examining the evidence. Altern Med Rev 2004, 9:4-16.
21. Stanislavov R, Nikolova V, Rohdewald P. Improvement of erectile function with Prelox: A randomized, double-blind, placebo-controlled, crossover trial. Int J Impot Res 2008, 20:173-80.
22. Cappelleri JC, Rosen RC. The Sexual Health Inventory for Men (SHIM): A 5-year review of research and clinical experience. Int J Impot Res 2005, 17:307-19.
23. Rosen RC, Cappelleri JC, Smith MD, Lipsky J, Pena BM. Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res 1999, 11:319-26.
24. Schnetzler G, Banks I, Kirby M, Zou KH, Symonds T. Characteristics, behaviors, and attitudes of men bypassing the healthcare system when obtaining phosphodiesterase type 5 inhibitors. J Sex Med 2010, 7:1237-46.
25. Vic JM. Specific aspects of erectile dysfunction and its treatment for community pharmacists. Int J Impot Res 2004, 16(2):S50-2. suppl
26. Dean J, Carr A, Carlsson M, Marfatia A, Schnetzler G, Symonds T. Correlation between community pharmacist and physician recommendations for treatment with a phosphodiesterase type 5 inhibitor. J Sex Med 2009, 6(2):113-93. suppl
27. Martinez P, Armando PD, Molina Guerra AC, Marti PM, Martinez MF. Relationship between cardiovascular risk factors and high blood pressure by community pharmacists in Spain. Pharm World Sci 2009, 31:406-12.